天津市武清区龙济医院治疗男性早泄天津市龙济包茎手术怎么样,龙济医院泌尿科电话多少,武清龙济泌尿外科男科医院怎么去,天津龙济泌尿服务如何,天津市龙济泌尿导航,天津市武清区龙济医院天津市武清区龙济男科医院,武清区龙济男科可信吗

"Edmond de Belamy" has made history as the first work of art produced by artificial intelligence to be sold at auction.The slightly blurry canvas print, which has been likened to works by the Old Masters, sold Thursday for 2,000 — dramatically exceeding its original estimate of ,000-,000 — at a Christie's auction in New York."Christie's continually stays attuned to changes in the art market and how technology can impact the creation and consumption of art," Richard Lloyd, international head of prints and multiples at Christie's, said in a statement before the auction. 600

SAN DIEGO (KGTV) - A severely injured horse trainer and her husband filed a lawsuit against SLR Training Center INC., the company that owns the San Luis Rey Downs Training Center in Bonsall. The nine-page complaint was filed March 18, and it focuses on the events of Dec. 7, 2017, when the Lilac Fire burned through the training facility. Martine Bellocq suffered burns to more than 60 percent of her body and lost a leg while trying to save racehorses, including her own. The court documents allege negligence on the part of the training facility. It also claims the San Luis Rey Downs facility “failed to keep a defensible space around structures.” It goes on to say “there were no fire suppression systems in place” and it “failed to have the foresight to have a means to evacuate the facility, or an emergency plan in place.” Bellocq’s attorney says her medical bills are racking up, currently in the hundreds of thousands of dollars. The attorney says the lawsuit is to recoup economic damages, resulting from injuries and the impact on her life. San Luis Rey Downs declined to give 10News a comment regarding the lawsuit. 1140

 Railing against much of the mainstream press, President Donald Trump continued to air his grievances with the media, honing in on NBC News anchor Chuck Todd."It's 1999, I'm on Meet the Press, a show now headed by sleepy eyes Chuck Todd," Trump recalled. "He's a sleeping son of a b----. I'll tell you."Trump made the remark during a speech on Saturday in Pennsylvania where he stopped to campaign for a special election set this Tuesday.  457

(AP) - With CBD showing up everywhere, U.S. regulators announced Tuesday they are exploring ways the marijuana extract could be used legally in foods, dietary supplements and cosmetics.The U.S. Food and Drug Administration said it will hold a public hearing May 31 to gather more information on the science, manufacturing and sale of cannabis compounds like CBD.In the meantime, it issued more warning letters to companies for making unapproved health claims about CBD products.Products containing CBD are already in stores and sold online, so it's easy to believe there must be something special about the ingredient. But the claims are largely unproven and quality control standards don't exist.RELATED: Can using CBD products cost someone their job? A look at what we know as U.S. regulators work out what will and won't be allowed:WHAT IS CBD?CBD is one of more than 100 compounds found in marijuana. It's extracted using alcohol or carbon dioxide in factories. It's added to oils, mixed into creams and lotions and sold in candies and liquid drops.Widely sold online, CBD now is going mainstream with major retailers offering salves and balms for the skin. Prices range from to 0 an ounce at high-end shops.CBD often comes from a cannabis plant known as hemp, which is defined by the U.S. government as having less than 0.3 percent THC. That's important because THC is what causes marijuana's mind-altering effect.CBD doesn't get people high, although it may be calming. Keep in mind some CBD products may contain THC, whether or not the label says so.RELATED: CBD-infused foods become rising trend in 2019People drug tested for work, addiction programs or because they take prescription opioids should take note: CBD products have caused people to fail urine drug screens.IS IT A MIRACLE CURE?If you believe the hype, CBD treats pain, relieves anxiety and both helps you sleep and keeps you focused.Most claims are based on studies in rats, mice or in test tubes. Some human research has been done, but in small numbers of people.One exception: For two rare seizure disorders, the evidence for CBD was strong enough to convince the FDA to approve GW Pharmaceutical's drug Epidiolex, which contains a purified form.The FDA announced Tuesday it has sent warning letters to three companies marketing products with what outgoing Commissioner Scott Gottlieb called "egregious, over-the-line claims" for CBD's effects on cancer, Alzheimer's disease, fibromyalgia and drug addiction. Gottlieb said the agency "won't tolerate this kind of deceptive marketing to vulnerable patients."RELATED: CVS Pharmacy selling cannabis-based products in stores in California, 7 other statesOnly drugs that have been reviewed by the FDA as safe and effective can make claims that they treat or prevent diseases or medical conditions. Many CBD producers attempt to sidestep the issue by using only vague language about general health and well-being.ANY SIDE EFFECTS?Scant research means not much is known about side effects either. In epilepsy research, CBD changed the way the body processed other drugs. That suggests CBD could interact with medications in ways we still don't know about.The most common side effects of the CBD drug Epidiolex include sleepiness, decreased appetite, diarrhea, increases in liver enzymes, exhaustion, rash and infections. FDA's Gottlieb noted Tuesday the potential for liver injury and other risks can be handled with medical supervision but less is known about how that would be managed without oversight. And there are questions about overlap if multiple CBD products are used.IS IT LEGAL?For now, the agency has said CBD is not allowed as an ingredient in food, drinks or dietary supplements.In stating its position, the FDA cited a provision of the law prohibiting food makers from using active drug ingredients or those that are the subject of substantial research. But the agency doesn't have the resources to police all the CBD products that are already available, said Marc Scheineson, a former FDA official.RELATED: Creator of Jelly Belly releases CBD-infused jelly beans"They're not going to pull a thousand products from the market," he said.The FDA's authority is over interstate commerce, and local officials have taken differing approaches. In New York, Los Angeles and elsewhere, officials are warning eateries to stop selling it in food and drinks. Maine passed a law allowing it in foods and other products in the state.Skin creams and cosmetics may be on safer footing with the FDA, but that too remains uncertain, said Camille Gourdet of RTI International, a nonprofit research institute in Durham, North Carolina. Though cosmetics aren't subject to premarket approval by the FDA, they could run afoul of regulations if they make specific health claims.Marijuana itself is illegal under federal law; most states that have legalized it allow marijuana-infused foods and candies, called edibles.ARE CBD LABELS ACCURATE?What you buy may contain much less CBD than the label states — or much more. It may include more THC than you want and it may be contaminated with mold or pesticides. Ask to see testing reports.A 2017 study in the Journal of the American Medical Association found 70 percent of CBD products were mislabeled. Researchers used an independent lab to test 84 products from 31 companies."You're really flying by the seat of your pants when you buy this stuff," said author Marcel Bonn-Miller of University of Pennsylvania.A product labeled as containing 100 milligrams of CBD may only have 5 milligrams or it may have 200, said Bonn-Miller, now an adviser for a company that sells CBD and other cannabis products. He did not work in the industry when he did the research."I wouldn't trust any of it until I knew independently it was safe," Bonn-Miller said.WHAT'S AHEAD?CBD research is planned or underway for cancer, autism, diabetic neuropathy, fibromyalgia, chronic pain, alcoholism with PTSD and psychiatric conditions. Results will take years, but some people aren't waiting."They are vulnerable and really hoping to feel better," said Karen Hande, a nurse practitioner at Vanderbilt-Ingram Cancer Center in Nashville.She became an expert in CBD because so many of her cancer patients were trying it. She tells them the evidence isn't enough to back the claims, but "they want to believe something is going to work." 6383

SAN DIEGO — SAN DIEGO (KGTV) - Chantal Breyfogle knows all too well the importance of early detection. Even though she has no family history and does self exam routines regularly, she's been diagnosed twice with breast cancer."I feel like I have double the opportunity and double the responsibility to make sure I give other women the opportunity to become a survivor," said Breyfogle.A big part of that is help from the Susan G. Komen Foundation. All of the money raised during their Race for the Cure 5K stays in San Diego. This event helps pay for mammograms, biopsies, support resources, and other medical needs for those who need it.Shaina Gross, the President and CEO of the Susan G. Komen Foundation San Diego Chapter says, " We hear all the time where people have to pay for their medication or their rent. And we don't want anyone to have to make that decision."Added support, Breyfogle says, is helpful as you deal with a disease that affects six women in San Diego a day. This disease also claims the life of one person a day.Breyfogle says, "I hope we will find cures and treatments so the next generation won't have to do this." 1151